chr3-121781772-G-A

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_001023570.4(IQCB1):​c.1381C>T​(p.Arg461*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000514 in 1,613,482 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000044 ( 0 hom. )

Consequence

IQCB1
NM_001023570.4 stop_gained

Scores

3
3
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:12

Conservation

PhyloP100: 2.27

Publications

13 publications found
Variant links:
Genes affected
IQCB1 (HGNC:28949): (IQ motif containing B1) This gene encodes a nephrocystin protein that interacts with calmodulin and the retinitis pigmentosa GTPase regulator protein. The encoded protein has a central coiled-coil region and two calmodulin-binding IQ domains. It is localized to the primary cilia of renal epithelial cells and connecting cilia of photoreceptor cells. The protein is thought to play a role in ciliary function. Defects in this gene result in Senior-Loken syndrome type 5. Alternative splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 6. [provided by RefSeq, Jan 2016]
IQCB1 Gene-Disease associations (from GenCC):
  • Senior-Loken syndrome 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Leber congenital amaurosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 3-121781772-G-A is Pathogenic according to our data. Variant chr3-121781772-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 1830.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IQCB1NM_001023570.4 linkc.1381C>T p.Arg461* stop_gained Exon 13 of 15 ENST00000310864.11 NP_001018864.2 Q15051-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IQCB1ENST00000310864.11 linkc.1381C>T p.Arg461* stop_gained Exon 13 of 15 1 NM_001023570.4 ENSP00000311505.6 Q15051-1
IQCB1ENST00000349820.10 linkc.982C>T p.Arg328* stop_gained Exon 10 of 12 1 ENSP00000323756.7 Q15051-2
IQCB1ENST00000393650.7 linkn.*359C>T non_coding_transcript_exon_variant Exon 12 of 14 5 ENSP00000377261.3 Q15051-3
IQCB1ENST00000393650.7 linkn.*359C>T 3_prime_UTR_variant Exon 12 of 14 5 ENSP00000377261.3 Q15051-3

Frequencies

GnomAD3 genomes
AF:
0.000118
AC:
18
AN:
151978
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.0000676
AC:
17
AN:
251372
AF XY:
0.0000736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00149
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000445
AC:
65
AN:
1461388
Hom.:
0
Cov.:
32
AF XY:
0.0000358
AC XY:
26
AN XY:
727012
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33464
American (AMR)
AF:
0.0000224
AC:
1
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.00153
AC:
40
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39674
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86240
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53380
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000126
AC:
14
AN:
1111670
Other (OTH)
AF:
0.000133
AC:
8
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000118
AC:
18
AN:
152094
Hom.:
0
Cov.:
31
AF XY:
0.0000941
AC XY:
7
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41488
American (AMR)
AF:
0.000262
AC:
4
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10574
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67994
Other (OTH)
AF:
0.000475
AC:
1
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.547
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000844
Hom.:
0
Bravo
AF:
0.000170
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.0000577
AC:
7
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Senior-Loken syndrome 5 Pathogenic:4
Feb 11, 2011
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Mar 26, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 04, 2024
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 20, 2024
Baylor Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Pathogenic:3
Dec 15, 2022
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Published functional studies demonstrate the mutant protein is incompetent in binding to Cep290, mislocalized, and unable to rescue ciliogenesis (Barbelanne et al., 2013); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 21866095, 25525159, 30586318, 23446637, 15723066, 21220633, 23847139, 31456290, 32581362, 33512896, 31589614, 36426739, 33535056, 28041643, 20881296, 28559085) -

Sep 16, 2018
Gharavi Laboratory, Columbia University
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

Jun 21, 2013
Eurofins Ntd Llc (ga)
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Pathogenic:1
Jul 25, 2023
Ambry Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1381C>T (p.R461*) alteration, located in exon 13 (coding exon 11) of the IQCB1 gene, consists of a C to T substitution at nucleotide position 1381. This changes the amino acid from a arginine (R) to a stop codon at amino acid position 461. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, the T allele has an overall frequency of 0.006% (18/282708) total alleles studied. The highest observed frequency was 0.154% (16/10370) of Ashkenazi Jewish alleles. This variant has been reported homozygous or compound heterozygous in multiple individuals with features consistent with IQCB1-related Senior-Loken syndrome (Otto, 2005; Otto, 2008; Chaki, 2011; Cideciyan, 2011; Estrada-Cuzcano, 2011; Stone, 2011; Halbritter, 2012; Coppieters, 2014; Wang, 2013; Rishi, 2021). One functional study has demonstrated that p.R461* disrupts protein-protein interactions with Cep290, causes mislocalization, and inhibits cilia formation in cells (Barbelanne, 2013). Based on the available evidence, this alteration is classified as pathogenic. -

Nephronophthisis Pathogenic:1
Jun 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Arg461*) in the IQCB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IQCB1 are known to be pathogenic (PMID: 15723066, 21901789, 23559409, 28041643). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individuals with Leber congenital amaurosis and/or Senior-Loken syndrome (PMID: 15723066, 20881296, 21220633, 21245082, 21866095, 23188109, 23847139, 24625443). ClinVar contains an entry for this variant (Variation ID: 1830). For these reasons, this variant has been classified as Pathogenic. -

Renal dysplasia and retinal aplasia Pathogenic:1
Jun 23, 2019
Sharon lab, Hadassah-Hebrew University Medical Center
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

IQCB1-related disorder Pathogenic:1
Feb 15, 2023
PreventionGenetics, part of Exact Sciences
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The IQCB1 c.1381C>T variant is predicted to result in premature protein termination (p.Arg461*). This variant has been reported in homozygous or compound heterozygous states in multiple individuals with Senior-Loken syndrome, Leber congenital amaurosis and/or other retinal diseases (Otto et al. 2005. PubMed ID: 15723066; Estrada-Cuzcano et al. 2011. PubMed ID: 20881296; Stone et al. 2017. PubMed ID: 28559085. Table S1). This variant is reported in 0.15% of alleles in individuals of Ashkenazi Jewish descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-121500619-G-A). However, the frequency data for this variant is considered unreliable since metrics indicate poor data quality at this position in the gnomAD database. Nonsense variants in IQCB1 are expected to be pathogenic. This variant is interpreted as pathogenic. -

Retinal dystrophy Pathogenic:1
Jan 01, 2015
NIHR Bioresource Rare Diseases, University of Cambridge
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.62
D
BayesDel_noAF
Pathogenic
0.59
CADD
Pathogenic
41
DANN
Uncertain
1.0
Eigen
Pathogenic
0.82
Eigen_PC
Uncertain
0.66
FATHMM_MKL
Uncertain
0.82
D
PhyloP100
2.3
Vest4
0.065
GERP RS
4.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=1/199
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121918244; hg19: chr3-121500619; API